TMPRSS2 and prostate carcinoma: Moreover, in a study conducted by Wilson et al., TMPRSS2 was found to be able to catalytically activate PAR-2 in prostate cancer cell lines, leading to the increased expression of matrix metalloproteinases 2 and 9.